Pharmafile Logo

free-spending

- PMLiVE

Communicating value to US Payers: Insights for Pharma and Medtech

What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging...

Petauri Evidence

Top 10 HEOR trends – A detailed look at ISPOR’s 2024–2025 topics

Top 10 HEOR trends – A detailed look at ISPOR’s 2024–2025 topics

Specialists from across Mtech Access to look at each of ISPOR’s top 10 HEOR trends for 2024–2025. Jump in as the Mtech Access experts give their hot take on each...

Petauri Evidence

A designer evaluating user research findings on a laptop

Demonstrating the value of UX research in pharma and healthcare

Demonstrating the value of UX research in pharma and healthcare can be difficult. Here, Graphite's Senior Clinical UX Researcher, Jack Burton, explains the importance of user research within the digital...

Graphite Digital

Early pipeline planning depicted with a pipe and data-oriented imagery.

Why it’s time to apply a payer lens to your early pipeline planning

Value, evidence, and market access experts Jan McKendrick and Andrea Hamlin reveal why applying a payer lens early in the value assessment of pipeline assets is essential for driving commercial...

Avalere Health

- PMLiVE

Born strategic – Why great strategists are both born and made

You’ve probably met the sort of people I mean. You might even have had the good fortune to work with them and to learn from them. That person who seems...

6 professional headshots of the 4 women and 2 men on the leadership team at Avalere

Data-driven policy and market access firm Avalere joins Fishawack Health

Fishawack Health bolsters its commercialization service offering with its largest addition to date, welcoming US-based policy, market access, and transformation leader Avalere.

Avalere Health

- PMLiVE

Fishawack Health expands its value, evidence, and market access capabilities with the acquisition of HEOR consultancy Policy Analysis Inc. (PAI)

Fishawack Health announces its expanded global Value, Evidence, and Access (VEA) capability for biopharmaceutical and medical technology companies, with a suite of end-to-end services spanning product lifecycle, coupled with unsurpassed...

Avalere Health

- PMLiVE

Nature’s way

There are business lessons to be learned from biological tragedies

- PMLiVE

Edging towards success

Evolution tells us to look for small advantages, not big leaps

- PMLiVE

Back to the future

Five years ago, an influential book used Darwin’s ideas to predict the future of the industry – how did that work out?

The Midas Touch

Smart, but small, science can turn old ideas into gold

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links